Skip to content
Trend Daily UK delivers breaking news, lifestyle tips, and …

Zimbabwe Turns Down ‘One-Sided’ US Healthcare Assistance Package Due to Data Concerns

Medical funding illustration
The offered US funding was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a major US healthcare agreement worth 367 million US dollars (£272m) spanning five years due to Washington's insistence on confidential biological samples.

This rejection was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa deemed the arrangement was "skewed".

An official representative later explained that the US was requesting health data for research and commercial purposes while was not willing to share the benefits from future treatments.

"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has called for more negotiations to reach a agreement acceptable to all parties so the nation's vital HIV programme can be sustained.

Broader Implications

This rejection follows a comparable situation in Kenya, where a high court halted a related deal with the US following legal challenges were filed about the safety of Kenyans' medical information.

After resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government agreements to boost openness and accountability.

Based on reports, 16 African countries have so far agreed to similar health pacts, constituting more than $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via US-supported programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to share its biological resources and data for a long time, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.

"Effectively, our country would supply the basic resources for medical research with no assurance that the final treatments would be accessible to our population if a new health crisis arise."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting systems previously set up via the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage future pandemics.

"This system is designed to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."

These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome further discussions with our American counterparts on how future collaboration could be arranged in a way that honours the independence and interests of both nations."

Medical Community Reaction

Medical experts expressed it recognised the official position, but urged that negotiations should continue considering a large portion of the country's Aids initiatives depended on international support.

"In cases where specific concerns arise, including those involving information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it commented.

This impasse underscores the continuing challenges between accepting vital foreign assistance and safeguarding local interests in an ever more data-driven world.

Written by

Tammy Parrish

Evelyn Reed is a seasoned journalist with a passion for uncovering stories in technology and culture, bringing fresh perspectives to readers.

Trend Daily UK

Type to search articles.